Normal Phosphate Levels May Predict CKD Progression
Serum phosphate within the normal range is a strong predictor of CKD progression, according to Italian researchers who presented a study at ASN’s Renal Week 2009.
Renal Week 2009 Hyperphosphatemia
Tablet Burden Lowest with Lanthanum Carbonate
CKD patients who used lanthanum carbonate to manage hyperphosphatemia had a lower mean tablet burden compared with those who took sevelamer hydrochloride or calcium acetate, according to researchers who presented a study at ASN’s Renal Week 2009.
Hemodialysis Patients Benefit from Residual Kidney Function
Hemodialysis patients who have residual kidney function have lower serum phosphate levels and use less phosphate binders than those without RKF, according to a study presented at ASN’s Renal Week 2009.
Hyperphosphatemia Afflicts Nearly Three-Fourths of HD Patients
Researchers who reviewed data from about 60,000 hemodialysis patients found that 73% of them experienced hyperphosphatemia according to a study presented at ASN’s Renal Week 2009.
Nocturnal Hemodialysis Improves Protein and Phosphorus Status
Patients who undergo in-center nocturnal hemodialysis have improved protein and phosphorus status compared with those treated with in-center conventional hemodialysis, according to a study that was presented at ASN’s Renal Week 2009.
Sevelamer May Have Benefits Beyond Phosphorus Lowering
Sevelamer treatment for hyperphosphatemia in dialysis patients may provide benefits in addition to lowering phosphorus, according to a study conducted in Taiwan that was presented at ASN’s Renal Week 2009.
Higher Dietary Phosphorus Intake Raises Mortality Risk
Higher dietary phosphorus intake is associated with increased mortality in patients on maintenance hemodialysis, data show.
Phosphate Knowledge Lacking Among Dialysis Patients
Dialysis patients’ understanding of issues related to phosphate control needs improvement, according to a study presented at the American Society of Nephrology’s Renal Week conference.
Higher Mortality Linked to Elevated Alkaline Phosphatase in CKD
Elevated serum alkaline phosphatase levels—which reflect increased bone turnover in CKD—are associated with increased mortality in patients with non-dialysis CKD, researchers have concluded in a study that was presented at ASN’s Renal Week 2009.
Phosphate Levels Higher in African-American CKD Patients
Among CKD patients, African Americans have significantly higher serum phosphate levels than whites, researchers have found, according to a study presented at ASN’s Renal Week 2009.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...